Skip to content

Medical-device intelligence

Tools built at Dyno

How MedTech Watch, Benchform, and Dyno serve distinct parts of medical-device research and development.

Different tools, connected by device development

MedTech Watch is operated by Dyno Health, Inc. Charles Denault is Dyno’s founder. The MedTech Watch editorial byline identifies the organization responsible for maintaining this site; it does not claim independent clinical review or personal review by a named regulatory expert.

Our research pages summarize source facts, preserve FDA identifiers, and link to original records. Guide publication, substantive revision, and source-check dates are maintained separately. Read our editorial standards or send a source link and proposed correction to hello@medtech.watch.

Research with MedTech Watch

Explore public FDA records, compare dated record activity, and follow selected companies and product codes. Paid monitoring adds a private watchlist and weekly brief. It is not validated postmarket surveillance.

Carry decisions into a product workflow

Benchform is being developed for medical-device requirements, risk, traceability, and release evidence. Its early-access evaluation is separate from MedTech Watch; qualification and approval for official quality use are pending.

Read Benchform’s research-to-decision workflow ↗

See what Dyno is developing

Dyno is developing an at-home, finger-prick testosterone assay. It is investigational, not FDA cleared or approved, not for sale, and its performance has not been validated. Its device-development work provides the context for these separate software tools.

Read about the tools built at Dyno ↗

Separate products and accounts

Following a link does not enroll you in another product or share your private watchlist or quality records. Optional analytics measures aggregate referral and conversion activity only after consent. Review your analytics choices.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗